News | November 21, 2025
EMA launches streamlined process to fast-track critical medicines, vaccines
The move is expected to be crucial during health crises
The move is expected to be crucial during health crises
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Consolidated revenue from operations stood at Rs. 111.05 crore
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Subscribe To Our Newsletter & Stay Updated
